INTRODUCTION
All bacterial pathogens encode mechanisms to acquire nutrients and macromolecules from their hosts. Legionella pneumophila is an intracellular bacterial pathogen whose natural host cells are diverse species of freshwater amoebae (Fields et al., 2002) . Upon inadvertent inhalation by humans, L. pneumophila can also replicate within alveolar macrophages to cause a severe pneumonia called Legionnaires' disease (Copenhaver et al., 2014) . Given the diversity of its host species, success as a pathogen requires L. pneumophila to target and modulate conserved host processes. To do this, L. pneumophila uses its Dot/Icm type IV secretion system to deliver more than 300 bacterial effector proteins into the host cell cytosol (Qiu and Luo, 2017) . Because of functional redundancy among effectors, genetic deletion of individual effector genes rarely imparts a significant growth defect, but loss of a functional Dot/Icm system renders L. pneumophila avirulent and unable to replicate intracellularly (Ensminger, 2016) . Numerous translocated L. pneumophila effectors target highly conserved host processes to establish the Legionella-containing vacuole, a replicative niche for the bacterium (Isberg et al., 2009) . Additional effectors target other conserved host processes. For example, as many as seven effectors have been identified that inhibit host protein synthesis (Barry et al., 2013; Belyi et al., 2008; Fontana et al., 2011; Shen et al., 2009 ). However, an L. pneumophila strain (D7) that lacks these seven effectors still inhibits host translation initiation via a Dot/Icm-dependent mechanism (Barry et al., 2017) . Thus, L. pneumophila likely encodes additional effectors that target conserved host signaling pathways that regulate translation initiation.
Although it has not been extensively studied, L. pneumophila also likely encodes effectors that promote acquisition of host nutrients, particularly amino acids. L. pneumophila is auxotrophic for several amino acids and requires host-derived amino acids for intracellular replication (Eylert et al., 2010; Sauer et al., 2005) . Amino-acid levels are tightly controlled in host cells. The mechanistic target of rapamycin complex 1 (mTORC1), a conserved protein complex consisting of the mTOR kinase and several regulatory proteins, is a critical regulator of the growth state of cells in response to the availability of amino acids and other nutrients (Efeyan et al., 2012) . Active mTORC1 represses autophagy and lysosome biosynthesis and stimulates translation initiation (Mohr and Sonenberg, 2012) . L. pneumophila has previously been reported to modulate mTORC1 activity in infected cells, but no effectors responsible for this modulation have been identified (Abshire et al., 2016; Ivanov and Roy, 2013) .
In this study, we report that previously characterized substrates of the Dot/Icm type IV secretion system have additional functions in regulating mTORC1 activity. The Legionella glucosyltransferase (Lgt) family of effectors was originally identified as a family of enzymes that potently inhibits host protein synthesis (Belyi et al., 2006) . Here, we show that protein synthesis inhibition by the Lgt effectors results in activation of mTORC1. We also report that a distinct family of effectors, the SidE/SdeABC (SidE) family, negatively regulates mTORC1 by catalyzing the ubiquitylation of Rag small GTPases that are important for mTORC1 amino-acid sensing. We propose that a joint effect of the Lgt and SidE effector families is to promote liberation of host amino acids for bacterial consumption.
RESULTS

An Effector Screen Identifies Lgt Effectors as Activators of mTORC1
We sought to investigate mechanisms by which L. pneumophila might liberate host amino acids for its consumption. Given that mTORC1 is an important regulator of host amino-acid metabolism, we decided to perform a qualitative screen to identify Dot/Icm effectors that activate mTORC1. To do this, we utilized a HEK293T cell line stably expressing transcription factor EB (TFEB) fused to EGFP (293T-TFEB-EGFP) as a reporter of mTORC1 activity (Settembre et al., 2012) . TFEB is a transcription factor that regulates lysosome biogenesis and is a target of mTORC1 (Settembre et al., 2012) . In the presence of amino acids, mTORC1 is active and phosphorylates TFEB, which is then retained in the cytosol. In the absence of amino acids, mTORC1 is inactive, and TFEB is hypophosphorylated and enters the nucleus to activate transcription of lysosome biogenesis genes ( Figure 1A) . We transfected the 293T-TFEB-EGFP reporter cells with 260 individual L. pneumophila Dot/Icm effectors and screened for effectors that prevented nuclear localization of TFEB upon amino-acid withdrawal.
Reporter cells transfected with expression vectors encoding lgt1, lgt2, or lgt3 exhibited constitutive TFEB cytosolic localization and mTORC1 activity, even under conditions of aminoacid withdrawal ( Figures 1A and 1B) . To validate these results, we assessed mTORC1-dependent phosphorylation of S6K1 at threonine 389 (T389), an mTORC1-specific substrate ( Figure 1C ). We observed that cells expressing Lgts showed robust T389 phosphorylation, even when starved of amino acids. Lgt-dependent phosphorylation of S6K1 T389 was mTORC1 dependent, since it was inhibited by Torin1, an inhibitor of mTORC1 kinase activity.
The Lgt effectors are a family of Legionella glucosyltransferases that were previously shown to target host elongation factor 1A (eEF1A) and thereby inhibit translation (Belyi et al., 2006) . Importantly, we found that mutant glucosyltransferase-dead Lgt effectors failed to activate mTORC1 ( Figure S1A ). Given that amino acids activate mTORC1, we reasoned that the Lgt family might indirectly activate mTORC1 by increasing the availability of intracellular amino acids via the inhibition of host protein synthesis. Consistent with this hypothesis, it has been shown previously that translation elongation inhibitors such as cycloheximide (CHX) can activate mTORC1, presumably through liberation of amino acids (Watanabe-Asano et al., 2014) . We confirmed this result and further found that an inhibitor of translation initiation, bruceantin, also activates mTORC1 ( Figure 1D ). In addition, the phosphorylation of 4E-BP1, another mTORC1 substrate, was increased in cells expressing the Lgt family (Figure S1B) . Thus, translation inhibition by diverse mechanisms activates mTORC1, suggesting that it is the block in protein synthesis and consequent liberation of amino acids, rather than another effect of the Lgts, that leads to mTORC1 activation.
To rule out the possibility that Lgt effectors activate mTORC1 via Akt, we also examined the phosphorylation state of Akt and saw no differences in cells transfected with Lgt1 or its glucosyltransferase-dead mutant ( Figure S1C ). In order to assess the effect of Lgts on mTORC1 in a more physiological setting, we infected bone-marrow-derived macrophages (BMMs) with a L. pneumophila strain that lacks the Lgt family and other known translation inhibitors (D7) (Barry et al., 2013; Fontana et al., 2011) . In order to prevent the potentially confounding effects of flagellin-induced NAIP5 inflammasome-dependent macrophage cell death (Molofsky et al., 2006; Ren et al., 2006) , we used a strain of L. pneumophila that lacks flagellin (DflaA) as the parental strain. Since TLR signaling is known also to activate mTORC1 with the DflaAD7 strain exhibit decreased mTORC1 activity (as measured by phospho-S6K1) compared to BMMs infected with DflaA ( Figure 1E ). mTORC1 activity was restored in cells infected with the DflaAD7 strain complemented with wild-type, but not glucosyltransferase-dead, lgt2 or lgt3. Thus, the Lgts appear to be the primary Dot/Icm-translocated effectors responsible for mTORC1 activation in infected macrophages. We were unable to observe a growth defect of the DflaAD7 strain during infection, even in amino-acid limiting conditions (Fontana et al., 2011 ; data not shown). The lack of a growth phenotype is likely explained by the prior observation that the DflaAD7 strain appears to encode yet additional effectors that impose a (delayed) block on host protein synthesis (Barry et al., 2017) . Nevertheless, taken together, our results indicate that L. pneumophila activates mTORC1 via secretion of Lgts, likely as an indirect effect of Lgtdependent translation inhibition and the consequent liberation of host amino acids.
An Effector Screen Identifies the SidE Family as Inhibitors of mTORC1
We also used the 293T-TFEB-eGFP reporter cells to screen for effectors that inhibit mTORC1. In this screen, reporter cells were transfected with constructs expressing individual effectors as before, but instead of withdrawing amino acids prior to imaging, we maintained the cells in complete media. Under these conditions, mTORC1 is active and TFEB-EGFP is cytosolic, unless an effector blocks mTORC1 activity. Most tested effectors did not block mTORC1, but we found that expression of sidE, sdeA, sdeB, or sdeC induced nuclear localization of TFEB (Figures 2A and 2B ). These four paralogs, referred to here collectively as the SidE family, are a group of recently characterized effectors that catalyze the ubiquitylation of Rab small GTPases and Reticulon-4 (Rtn4) via an unusual biochemical mechanism that does not require E1 or E2 enzymes (Bhogaraju et al., 2016; Kotewicz et al., 2017; Qiu et al., 2016) . To confirm that the SidE effectors interfere with mTORC1 activity, we found that S6K1 phosphorylation was also inhibited in HEK293T cells expressing the SidE family ( Figure 2C ). The inhibition by the SidE family required the mART (mono-ADP ribosyltransferase) motif required for catalyzing ubiquitylation. Importantly, inhibition of mTORC1 by SidE effectors was comparable in magnitude to the effect of dominant-negative RagB and RagD (Rags DN ), which inhibit mTORC1 (Han et al., 2012; Oshiro et al., 2014) . We also observed decreased phosphorylation of 4E-BP1 in cells expressing the SidE family ( Figure S1D ). Moreover, the inhibitory effect of SidE did not appear to be due to modulation of Akt, as (E) Bone-marrow-derived macrophages from Myd88 À/À mice were infected with the indicated strains at MOI 3. 9 hr post-infection, amino acids were withdrawn from the media for 1 hr. 10 hr post-infection, cell lysates were harvested and probed as in (C). Asterisk indicates catalytically inactive alleles. Error bars in (B) represent mean ± SD. In (C)-(E), data shown are representative of least three independent experiments. *p < 0.001, statistical test: unpaired t test. See also Figure S1 .
phosphorylation of Akt at T308 or S473 was unaffected by SdeA transfection ( Figure S1E ). We next assessed the effects of SidE effectors during L. pneumophila infection of BMMs. We were unable to observe an effect on mTORC1 signaling in cells infected with a strain lacking the SidE family (DsidEs) when pulsed with amino acids ( Figure S2A ). This may be due to the presence of additional mTORC1 inhibitors. We were able to observe a modest growth defect during infection with strains lacking the SidE family ( Figure S2B ). This growth defect was further exacerbated in amino-acid limiting conditions and partially rescued upon complementation with a plasmid expressing wild-type, but not mART-dead, sdeA ( Figure S2B ). However, because SidE effectors have global effects on ubiquitylation, vesicular trafficking, (E) HEK293T cells were transfected with the indicated constructs and treated with 250 nM Torin1 4 hr prior to harvest as indicated. 1 hr prior to harvest, amino acids were withdrawn for 50 min and then replenished for 10 min. 24 hr post-transfection, the cells were lysed and probed as in (C). Error bars in (B) and (D) represent mean ± SD. In (C) and (E), data shown are representative of least three independent experiments. *p < 0.05; **p < 0.01, statistical test: unpaired t test. See also Figures S1 and S2.
and the tubular endoplasmic reticulum in host cells (Bhogaraju et al., 2016; Kotewicz et al., 2017; Qiu et al., 2016) , the cause of this growth defect may not solely be due to the effects on mTORC1 signaling. In summary, our results suggest that mTORC1 inhibition is an additional function of the SidE family.
Inhibition of Protein Synthesis Is a Common Effect of Lgt and SidE Effectors
Initially, we were puzzled as to why L. pneumophila would encode two families of effectors with opposing effects on mTORC1. However, this counterproductive behavior could be rationalized if both families of effectors had an underlying common purpose, namely, inhibition of host protein synthesis. The Lgts have already been shown to act as direct inhibitors of translation elongation (Belyi et al., 2006) . To test whether negative regulation of mTORC1 by SidE effectors might also block host protein synthesis, we measured the incorporation of [ 35 S]-labeled methionine into effector-transfected cells. We observed that cells expressing sidE paralogs sdeA-C, but not the mART catalytic mutants of sdeA-C, exhibited a decrease in protein synthesis ( Figure 2D ). These data suggest that inhibition of protein synthesis is a common downstream effect of both the Lgt and SidE effector families.
The SidE Effectors Ubiquitylate Rag Small GTPases
Protein synthesis inhibition by the Lgt effectors results in mTORC1 activation (Figure 1) . In order for SidE effectors to block translation without activating mTORC1, we hypothesized that the SidE effectors must act at the level of, or downstream of, the Rag small GTPases that are required for mTORC1 responsiveness to amino acids. Otherwise, the liberated amino acids from SidE-mediated translation arrest would, presumably, activate mTORC1. Thus, to test whether SidE effectors act at the level or downstream of Rags, we co-expressed constitutively active Rags (Rags CA ) with sdeA or sdeA mART . The activation of mTORC1 by Rags CA was abolished in the presence of sdeA but not in the presence of sdeA mART ( Figure 2E ). This result implies that SdeA blinds mTORC1 to elevated intracellular levels of amino acids, resulting in constitutive inhibition of mTORC1, even in the presence of elevated amino-acid levels associated with protein synthesis inhibition. Given these results, we wondered whether the Rags could be directly targeted by SdeA. SdeA has been reported to catalyze the mART-dependent ubiquitylation of Rab small GTPases (Bhogaraju et al., 2016; Qiu et al., 2016) . Indeed, we observed that co-transfection of SdeA with the small GTPases RagB or RagD resulted in a molecular-weight shift consistent with monoubiquitylation ( Figure 3A ) (Bhogaraju et al., 2016; Kotewicz et al., 2017; Qiu et al., 2016) . The molecular-weight shift required the mART motif in SdeA, similar to what has previously been observed upon SdeA-dependent modification of the Rab small GTPases and Rtn4 ( Figure 3A) . In vitro reactions with recombinant purified proteins show that the SdeA-dependent modification of the Rags depends on the presence of NAD and ubiquitin ( Figure 3B ). This suggests that SdeA inhibits mTORC1 by directly inhibiting the Rag small GTPases.
If the SidE effectors inhibit Rag-dependent amino-acid sensing by mTORC1, then, we reasoned, they should be able to dominantly abolish the ability of Lgt or other translation inhibitors to activate mTORC1. However, when we attempted to co-express Lgts with SidE effectors in transfected 293T cells, we observed that the Lgts blocked SidE effector expression (presumably, via inhibition of translation). To circumvent this technical difficulty, we mimicked the effect of the Lgts by adding a chemical translation inhibitor (cycloheximide or bruceantin) after transfected SdeA effectors were expressed. In line with our hypothesis, the activation of mTORC1 by these translation inhibitors was abrogated in the presence of catalytically active SdeA ( Figure 3C ). Based on these results, we hypothesize that a role of the SidE family is to blind mTORC1 to the amino acids liberated by the Lgt effectors and other translation inhibitors. Taken together, our results suggest a model in which protein synthesis inhibition and mTORC1 inhibition might synergistically elevate the pools of intracellular amino acids in cells. Indeed, we found that cells treated with a protein synthesis inhibitor (cycloheximide) and an mTORC1 inhibitor (Torin1) displayed elevated levels of several amino acids ( Figure S3 ). Not all amino-acid levels were increased, however, underlining the complexity of amino-acid metabolism in cells. Importantly, though, several of the increased amino acids (e.g., isoleucine, arginine, and phenylalanine) are ones for which L. pneumophila is reported to be an auxotroph (Eylert et al., 2010) .
L. pneumophila Strain that Lacks All Known Translation Inhibitors Still Inhibits Host Protein Synthesis
Given the aforementioned results, we asked whether a L. pneumophila strain that lacks all known translation inhibitors is still able to inhibit host protein synthesis. Indeed, expression of Lgt3 combined with chemical inhibition of mTORC1 led to synergistic inhibition of protein synthesis ( Figure 4A ). The DflaAD7 strain, which lacks Lgts and other effectors, still inhibits translation (Barry et al., 2017 (Barry et al., , 2013 . We therefore tested whether deletion of the SidE family in the DflaAD7 background restores host protein synthesis. We infected BMMs with strains of L. pneumophila lacking a varying number of translation inhibitors. A strain lacking the seven known translation inhibitors as well as the four members of the SidE family (DflaAD11) still inhibited translation ( Figure 4B sis and/or perhaps additional effectors that inhibit mTORC1. The high level of redundancy demonstrated by these results suggests that translation inhibition is important for L. pneumophila fitness during infection.
DISCUSSION
L. pneumophila is an amino acid auxotroph and must, therefore, target conserved host processes in order to obtain amino acids. Our data led us to propose a speculative model for how L. pneumophila uses multiple effectors to inhibit mTORC1 and host protein synthesis-and thereby liberate host amino acids for bacterial consumption-without engaging autophagic responses that might restrict bacterial replication ( Figure S4A ). Of course, the effectors we identified have been shown to have diverse effects on cells, and it is therefore likely that mTORC1 modulation may only be a part of the complex biological roles of these effectors (Bhogaraju et al., 2016; Hempstead and Isberg, 2015; Kotewicz et al., 2017; Qiu et al., 2016; TreacyAbarca and Mukherjee, 2015) .
A previous report suggested that L. pneumophila requires an effector called AnkB to liberate host amino acids via ubiquitinproteasome-mediated degradation of host proteins (Price et al., 2011) . In this report, ankB mutants in the AA100 strain background were found to be severely attenuated for intracellular growth. However, in our experiments, we could not detect any significant defects in intracellular replication of ankB mutants ( Figure S4B ). We cannot offer an explanation for this discrepancy, but it would not be surprising if L. pneumophila encodes multiple redundant strategies to acquire host amino acids.
Our results provide insights into the long-standing question of how L. pneumophila obtains amino acids in order to replicate in its intracellular niche. Our data are consistent with emerging evidence that mTORC1 is a key signaling hub in numerous bacterial infections (Jaramillo et al., 2011; Lu et al., 2015; Tattoli et al., 2012) . Indeed, mTORC1 regulates known antimicrobial factors such as autophagy and lysosomes. In addition, the importance of mTORC1 as a key regulator of host nutrients makes it a lucrative target for pathogens. Future studies will likely identify additional mTORC1 regulators in other intracellular pathogens.
EXPERIMENTAL PROCEDURES
Effector Library Screen A library of L. pneumophila Dot/Icm effectors was maintained as previously described (Barry et al., 2013) and adapted from (Losick et al., 2010) . 4 3 10 4 HEK293T TFEB-EGFP cells were reverse transfected with 100 ng of each effector with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were plated on clear-bottom 96-well imaging plates (E&K Scientific) seeded with fibronectin (Corning). 24 hr post-transfection, cells were fixed and stained with DAPI. GFP and DAPI were imaged using a Molecular Devices ImageXpress Micro.
In Vitro Ubiquitylation Assay
To purify FLAG-RagB or FLAG-RagD from mammalian cells, 293T cells transfected with the indicated plasmids for 24 hr were lysed with RIPA buffer. ANTI-FLAG M2 Affinity Gel was added to cleared lysates obtained by centrifugation at 12,000 3 g for 10 min. The mixtures were incubated at 4 C with agitation for 4 hr. Unbound proteins were removed by washing the beads three times with RIPA buffer, and the FLAG-tagged proteins were eluted with 450 mg/mL 33 FLAG peptide (Sigma). A ubiquitylation assay was performed at 37 C for 2 hr in a reaction buffer containing 50 mM Tris-HCl (pH = 7.5), 0.4 mM b-nicotinamide adenine dinucleotide (b-NAD) (SigmaAldrich), and 1 mM DTT. Each 50-mL reaction contains 10 mg ubiquitin, 5 mg SdeA or SdeA mART , and 5 mg FLAG-RagB or FLAG-RagD. Reactions were terminated by adding 53 SDS loading buffer. Samples were subjected to SDS-PAGE followed by Coomassie brilliant blue staining or western blot with FLAG antibody.
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For detailed experimental procedures, please see the Supplemental Experimental Procedures.
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